Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male
Serous ovarian cancer
DOI:
10.1016/j.gore.2023.101190
Publication Date:
2023-04-15T11:12:32Z
AUTHORS (6)
ABSTRACT
•Low grade serous (LGS) ovarian cancer is an uncommon cancer.•Androgen receptor expression testing not routinely performed in patients with LGS cancer.•Systemic androgen levels may be elevated PCOS or those taking exogenous testosterone.•Consideration should made to include for these patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (14)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....